Prevalencia de hallazgos compatibles con onicopatía psoriásica en población general y su correlación con síntomas músculo esqueléticos en el Hospital Teodoro Maldonado Carbo durante octubre del 2017 a febrero del 2018.

Abstract

Introduction: Psoriasis is a chronic inflammatory disease that affects 2% of the general population, comprising in its spectrum cutaneous, joint (psoriatic arthritis) and nail manifestations (nail psoriasis). Generally, there is an association between these types as predictive factors of psoriatic arthritis that is the entity that most affects quality of life, so to determi ne the presence of nail lesions compatible with nail psoriasis in a medium such as ours where it is unknown its prevalence in the general population without a diagnosis of psoriasis or arthritis would serve as a screening method for potential patients with a tendency to have joint involvement. Objective: Determinate the prevalence of nail lesions compatible with psoriatic onychopathy in a population without psoriasis who attend the outpatient clinic of the HTMC during the established period. Materials and methods: an observational, descriptive and cross-sectional study was carried out with a sample of 350 people in outpatient and HTMC hospitalization services that met the inclusion criteria of this study. Results: the prevalence of nail lesions in people without psoriasis was 64.11%, the most frequent being stretch marks in 57.60% of the cases. There is a probability that musculoskeletal symptoms develop in the presence of these symptoms (OR: 5.28 and 4.19) and there is a significant correlation (, 349) between their presence and peripheral articular pain and with the diagnosis of arthritis (, 220). Conclusions: nail lesions were present in more than half of the population wi thout psoriasis, there is a likelihood that in the presence of these develop musculoskeletal symptoms and there is significant correlation between their presence and these symptoms such as peripheral joint pain, neck pain and low back pain in the last 3 months.